Literature DB >> 32346814

Severe hypocalcemia in a thyroidectomized woman with Covid-19 infection.

Simonetta Bossoni1, Laura Chiesa1, Andrea Giustina2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32346814      PMCID: PMC7188455          DOI: 10.1007/s12020-020-02326-0

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


× No keyword cloud information.
Dear Editor, A 72-year-old woman was admitted to the hospital with acute perioral paresthesia and dysarthria that she never experienced before. She reported mild fever and headache for the previous 3 days. She had low serum total (4.75 mg/dl) and ionized (2.09 mg/dl) calcium, hyperphosphatemia (5.2 mg/dl), slightly increased serum creatinine (1.54 mg/dl), and respiratory alkalosis (pH 7.5, PCO2 29 mmHg, PO2 74 mmHg). Total proteins and albumin were normal (69.2 g/L and 40 g/L, respectively). She had lymphocytopenia, increased lactate dehydrogenase (515 IU/L), and C-reactive protein levels (28.2 mg/L). She reported total thyroidectomy 19 years ago on l-thyroxine 100 μg/day, arterial hypertension on angiotensin-converting enzyme inhibitors, and hydrochlorothiazide and mild renal insufficiency from several years. The chest X-ray did not show signs of pneumonia. Nasopharyngeal swab for Covid-19 was performed due to contact with a suspect infected subject. Intravenous infusion of calcium gluconate was initiated with immediate beneficial effects on hypocalcemic symptoms and progressive amelioration of calcium so she could be switched to oral treatment. The patient resulted positive to Covid-19 test. PTH was 10 pg/ml (n.r. 15–65) and 25-OH vitamin D 8 ng/ml, with normal FT4 and TSH. The patient underwent resolution of fever and headache and was discharged after 9 days with normal calcemia (9.1 mg/dl) on oral calcitriol 0.25 μg/day and calcium carbonate 1000 mg/day [1]. This is the first case of Covid-19 infection as the possible precipitating cause of subclinical post-surgical hypoparathyroidism presenting with severe hypocalcemia. Hypocalcemia was already shown to be common in patients with SARS (60% of patients at hospital admission), although generally mild [2], and in patients with Ebola virus disease (62%) [3]. So far, hypocalcemia was not reported among the main laboratory features of Covid-19 infection [4]. In this case, besides the previous thyroidectomy, possible contributing factors could have been renal insufficiency, hydrochlorothiazide treatment (although both long-standing), and respiratory alkalosis which is quite commonly reported also in seriously ill Covid-19 patients [4]. This case suggests that hypocalcemia may occur also in Covid-19 infection. Therefore, all patients with postsurgical hypoparathyroidism should continue their treatment to avoid severe acute hypocalcemia which can be life-threatening [1] and since vitamin D deficiency, worsened by home confinement, may predispose to systemic infections [5]. Moreover, mild hypoparathyroid patients not requiring chronic treatment should undergo careful surveillance in areas characterized by the outbreak of Covid infection. Finally, since hypocalcemia may have a negative impact on cardiac outcomes [4], we suggest calcium evaluation and monitoring in all hospitalized patients with Covid-19 infection.
  5 in total

Review 1.  Treatment of hypoparathyroidism.

Authors:  Francesco Tecilazich; Anna Maria Formenti; Stefano Frara; Raffaele Giubbini; Andrea Giustina
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2018-12-06       Impact factor: 4.690

2.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

Review 3.  Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions.

Authors:  Roger Bouillon; Claudio Marcocci; Geert Carmeliet; Daniel Bikle; John H White; Bess Dawson-Hughes; Paul Lips; Craig F Munns; Marise Lazaretti-Castro; Andrea Giustina; John Bilezikian
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

4.  Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.

Authors:  Christopher M Booth; Larissa M Matukas; George A Tomlinson; Anita R Rachlis; David B Rose; Hy A Dwosh; Sharon L Walmsley; Tony Mazzulli; Monica Avendano; Peter Derkach; Issa E Ephtimios; Ian Kitai; Barbara D Mederski; Steven B Shadowitz; Wayne L Gold; Laura A Hawryluck; Elizabeth Rea; Jordan S Chenkin; David W Cescon; Susan M Poutanen; Allan S Detsky
Journal:  JAMA       Date:  2003-05-06       Impact factor: 56.272

5.  Clinical Management of Ebola Virus Disease in the United States and Europe.

Authors:  Timothy M Uyeki; Aneesh K Mehta; Richard T Davey; Allison M Liddell; Timo Wolf; Pauline Vetter; Stefan Schmiedel; Thomas Grünewald; Michael Jacobs; Jose R Arribas; Laura Evans; Angela L Hewlett; Arne B Brantsaeter; Giuseppe Ippolito; Christophe Rapp; Andy I M Hoepelman; Julie Gutman
Journal:  N Engl J Med       Date:  2016-02-18       Impact factor: 91.245

  5 in total
  17 in total

Review 1.  The osteo-metabolic phenotype of COVID-19: an update.

Authors:  Luigi di Filippo; Stefano Frara; Mauro Doga; Andrea Giustina
Journal:  Endocrine       Date:  2022-07-20       Impact factor: 3.925

Review 2.  Hypovitaminosis D and the endocrine phenotype of COVID-19.

Authors:  Andrea Giustina
Journal:  Endocrine       Date:  2021-03-18       Impact factor: 3.925

Review 3.  Hypocalcemia in COVID-19: Prevalence, clinical significance and therapeutic implications.

Authors:  Luigi di Filippo; Mauro Doga; Stefano Frara; Andrea Giustina
Journal:  Rev Endocr Metab Disord       Date:  2021-04-13       Impact factor: 9.306

Review 4.  Endocrine and metabolic aspects of the COVID-19 pandemic.

Authors:  Mónica Marazuela; Andrea Giustina; Manuel Puig-Domingo
Journal:  Rev Endocr Metab Disord       Date:  2020-12       Impact factor: 6.514

5.  A Basic Review of the Preliminary Evidence That COVID-19 Risk and Severity Is Increased in Vitamin D Deficiency.

Authors:  Linda L Benskin
Journal:  Front Public Health       Date:  2020-09-10

6.  Decompensated primary hypoparathyroidism in a patient with COVID-19.

Authors:  Jean-Baptiste Bonnet; Elise Berchoux; Ariane Sultan
Journal:  Ann Endocrinol (Paris)       Date:  2021-03-04       Impact factor: 2.478

7.  Hypocalcemia is a distinctive biochemical feature of hospitalized COVID-19 patients.

Authors:  Luigi di Filippo; Anna Maria Formenti; Mauro Doga; Stefano Frara; Patrizia Rovere-Querini; Emanuele Bosi; Michele Carlucci; Andrea Giustina
Journal:  Endocrine       Date:  2020-11-09       Impact factor: 3.925

8.  Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19.

Authors:  Luigi Di Filippo; Anna Maria Formenti; Patrizia Rovere-Querini; Michele Carlucci; Caterina Conte; Fabio Ciceri; Alberto Zangrillo; Andrea Giustina
Journal:  Endocrine       Date:  2020-06-12       Impact factor: 3.925

9.  Are women with osteoporosis treated with denosumab at risk of severe COVID-19?

Authors:  Anna Maria Formenti; Erika Pedone; Luigi di Filippo; Fabio Massimo Ulivieri; Andrea Giustina
Journal:  Endocrine       Date:  2020-09-20       Impact factor: 3.925

10.  Hypocalcemia: the quest for the cause of a major biochemical feature of COVID-19.

Authors:  Luigi di Filippo; Anna Maria Formenti; Andrea Giustina
Journal:  Endocrine       Date:  2020-10-22       Impact factor: 3.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.